Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about gene therapy

Recent news which mentions gene therapy

< Previous 1 2 3 Next >
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
Tickers AGTC
Tags Market News News Health Care
From Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags News Briefs Penny Stocks
From Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
Tickers PFE
Tags General FDA Market News
From Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
Tickers OCGN
Tags General Small Cap Briefs
From Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
Tags antibody gene therapy cell therapy
From PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
Tickers FOLD
Tags Trading Ideas gene therapy Health Care
From Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags FDA Small Cap General
From Benzinga
Why Bluebird Bio Shares Are Tumbling Today
Tickers BLUE
Tags Health Care gene therapy Trading Ideas
From Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
Tickers ARYD FOLD
Tags M&A Market News FOLD
From Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
Tickers TAK TKPHF
Tags General Biotech Benzinga
From Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
Tickers BMRN
Tags Market News General FDA
From Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
Tickers RGNX
Tags News RGNX Phase 1 Trial
From Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Tickers AVRO
Tags General AVRO Phase 2 Trial
From Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
Tickers SGMO
Tags Market News News Health Care
From Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
Tickers SIOX
Tags Management General Biotech
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
Tickers TSHA
Tags Market News General Biotech
From Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
Tickers TSHA
Tags Market News Trading Ideas gene therapy
From Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
Tickers FBIO MBIO
Tags Market News Health Care Penny Stocks
From Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
Tickers BLUE
Tags FDA Small Cap General
From Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
Tickers SRPT
Tags Market News SRPT Contracts
From Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
Tickers BLUE
Tags why it's moving BLUE Market News
From Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
Tickers BMRN
Tags Benzinga gene therapy Health Care
From Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
Tickers PFE
Tags FDA General Movers
From Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
Tickers ADVM
Tags Benzinga Biotech Briefs
From Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
Tickers BLUE
Tags FDA Small Cap General
From Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
Tickers BLUE
Tags Biotech Benzinga Briefs
From Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
Tickers QURE
Tags Phase 2 Trial Huntington's Disease Small Cap
From Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
Tickers BLUE
Tags ASH21 BLUE Market News
From Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
Tickers BLUE
Tags News gene therapy Trading Ideas
From Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
Tickers SELB
Tags Movers Biotech Benzinga
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.